Medical News

RSS

DSS VistA Chemotherapy Manager goes live at San Francisco VA Medical Center

DSS, Inc., a leading provider of software development, integration, project management, implementation and support of VistA, today announced that its customized VistA Chemotherapy Manager (VCM) system is now live and in production at the San Francisco VA Medical Center.

7 Nov 2011

States trying to wrangle Medicaid costs, with some unintended consequences

Wisconsin is not alone in dealing with the thorny task of trying to lower the cost of its health care programs for low-income residents. Massachusetts no longer pays for restorative dental care and dentures. Washington no longer covers eyeglasses and hearing aids. Minnesota no long covers chiropractic care. … Every state plans to implement at least one policy to control Medicaid spending this fiscal year.

7 Nov 2011

Cubist announces commencement of tender offer for all outstanding shares of Adolor common stock

Cubist Pharmaceuticals, Inc. today announced the commencement of its tender offer for all outstanding shares of the common stock of Adolor Corporation for $4.25 per share in cash, plus one nontransferable Contingent Payment Right entitling the holder to receive additional cash payments of up to $4.50 for each share tendered if certain regulatory approvals and/or commercialization milestones for ADL5945 are achieved.

7 Nov 2011

Insurance Commissioners delay vote on brokers' fees

The National Association Of Insurance Commissioners meeting could not come to a consensus on the issue of whether to remove broker and agent fees from the expenses that insurance companies can count as administrative costs under the health law. In the meantime, GOP lawmakers have asked the IRS commissioner to clarify that individuals in state exchanges get any tax credits created under the new law.

7 Nov 2011

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company.

7 Nov 2011

Blue Shield of Calif. turns to retail stores; Poll finds workers' share of health costs growing

Insurer's retail outlet in San Francisco will be in a supermarket. Meanwhile, a poll of large U.S. employer health spending by Modern Healthcare finds workers' costs are increasing.

7 Nov 2011

SurgLine to deliver first surgical instrumentation products to Denver hospital system

China Nuvo Solar Energy, Inc. today announced that its wholly owned subsidiary, SurgLine will deliver its first surgical instrumentation products to one of Denver's largest acute care hospital systems for use by one of its outpatient surgery centers.

7 Nov 2011

Proposals to raise Medicare age could raise costs too

NPR reports that raising the Medicare age could shift higher health care costs to others instead of saving money, while some lawmakers send a letter to the super committee opposing changing the tax exclusion for employer-sponsored health care.

7 Nov 2011

Conway to deploy PatientKeeper's physician healthcare information systems

PatientKeeper, Inc., the leading provider of physician healthcare information systems, today announced that Conway Medical Center has purchased PatientKeeper's suite of advanced clinical applications to automate physician workflow and drive physician adoption of healthcare information technology at their 210-bed hospital located near Myrtle Beach, South Carolina.

7 Nov 2011

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).

7 Nov 2011

Groups sound off on exchanges as governors wrestle with HHS over control

The issue of shaping health insurance exchanges is raising controversy even as states worry they'll bear the brunt of the public's anger over the law.

7 Nov 2011

HyQ phase III study data in patients with primary immunodeficiencies presented at ACAAI meeting

Baxter International Inc. today announced the presentation of its phase III study data for HyQ, an investigational combination immunoglobulin (IG) product for use in patients with primary immunodeficiencies (PI).

From Baxter International Inc. 7 Nov 2011

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the launches of several promising emerging therapies, the prostate cancer drug market will experience robust growth over the next decade, increasing from $3.6 billion in 2010 to $10.1 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

7 Nov 2011

Abortion and 'personhood' on GOP campaign agenda

State-level initiatives to restrict access to abortions help make social issues a major focus of the Republican presidential nomination contest.

7 Nov 2011

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.

From Medtronic 7 Nov 2011

NanoString closes $20M Series D round of equity financing

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.

From NanoString Technologies 7 Nov 2011

Mediterranean Diet beneficial even without weight loss

The benefits of the Mediterranean Diet go beyond weight loss, even when weight loss isn't achieved. Researchers from St. Vincent's Hospital, Melbourne, studied 12 patients without diabetes who had nonalcoholic fatty liver disease (NAFLD), and the results of their study demonstrated that liver health was improved even without weight loss.

7 Nov 2011

Medical News

DSS VistA Chemotherapy Manager goes live at San Francisco VA Medical Center

States trying to wrangle Medicaid costs, with some unintended consequences

Cubist announces commencement of tender offer for all outstanding shares of Adolor common stock

Insurance Commissioners delay vote on brokers' fees

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

Blue Shield of Calif. turns to retail stores; Poll finds workers' share of health costs growing

SurgLine to deliver first surgical instrumentation products to Denver hospital system

Proposals to raise Medicare age could raise costs too

Conway to deploy PatientKeeper's physician healthcare information systems

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Groups sound off on exchanges as governors wrestle with HHS over control

HyQ phase III study data in patients with primary immunodeficiencies presented at ACAAI meeting

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Abortion and 'personhood' on GOP campaign agenda

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

NanoString closes $20M Series D round of equity financing

Mediterranean Diet beneficial even without weight loss

A.P. Pharma's third quarter net loss increases to $4.2 million

NewCardio's automated cardiac safety solution selected by top pharma company for Phase I drug study

Zimmer commences $550M public offering of senior notes

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News